Description

Wageningen UR is going to be investing in synthetic biology, one of the investment themes mentioned in the strategic plan. This is a new discipline, in which researchers rebuild and design bacteria for industrial purposes. Professor Martins dos Santos, who recently acquired two large EU projects, will write an action plan
Period1 Jan 2015

Media coverage

1

Media coverage